Meribank Biotech Co., Ltd (4724.TWO)
TWD 15.35
(-21.48%)
TWD 15.35
(-21.48%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -92.56 Million TWD | -24.42% |
| 2022 | -70.07 Million TWD | -11.61% |
| 2021 | -68.59 Million TWD | -145.38% |
| 2020 | -29.94 Million TWD | 42.98% |
| 2019 | -38.58 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -13.27 Million TWD | 0.0% |
| 2024 Q1 | -13.27 Million TWD | 54.19% |
| 2023 Q3 | -28.97 Million TWD | -12.65% |
| 2023 FY | - TWD | -24.42% |
| 2023 Q2 | -25.72 Million TWD | 0.0% |
| 2023 Q1 | -25.72 Million TWD | 1.57% |
| 2023 Q4 | -28.97 Million TWD | 0.0% |
| 2022 FY | - TWD | -11.61% |
| 2022 Q4 | -26.13 Million TWD | 0.0% |
| 2022 Q3 | -26.13 Million TWD | 0.0% |
| 2021 FY | - TWD | -145.38% |
| 2020 FY | - TWD | 42.98% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -100.162% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 123.517% |
| Level Biotechnology Inc. | 98.7 Million TWD | 193.778% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -106.896% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -28.355% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -266.833% |
| GlycoNex Incorporation | -126.82 Million TWD | 27.016% |
| VBI | -6.97 Million TWD | -1227.639% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 35.584% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 524.406% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -422.188% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 10.666% |
| Visgeneer Inc. | 973 Thousand TWD | 9613.155% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 72.734% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 109.884% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 192.714% |
| Neith Corporation | -33.61 Million TWD | -175.403% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 90.661% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -5228.9% |
| Enimmune corporation | -228.96 Million TWD | 59.573% |
| TaiRx, Inc. | -208.64 Million TWD | 55.636% |
| CHO Pharma, Inc. | -277.73 Million TWD | 66.672% |
| EirGenix Inc. | -664.4 Million TWD | 86.068% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 225.248% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 233.872% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 91.361% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 18.163% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 365.696% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -48.479% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -251.951% |
| RBC Bioscience Corporation | 36.54 Million TWD | 353.271% |
| BiOptic Inc. | 65.03 Million TWD | 242.321% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 86.437% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -180.443% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -68.557% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 121.35% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -15.6% |
| NaviFUS Corp. | -55.79 Million TWD | -65.898% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -457.676% |
| Sinew Pharma Inc. | -163.63 Million TWD | 43.432% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -50.509% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 148.109% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 59.165% |
| AP Biosciences Inc | -325.51 Million TWD | 71.564% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 91.139% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -158.224% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 417.758% |
| Intech Biopharm Corporation | -219.58 Million TWD | 57.846% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 86.271% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -105.92% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 42.456% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 114.121% |
| TCI GENE Inc. | 25.98 Million TWD | 456.272% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 16.337% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 67.383% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 36.588% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 768.325% |
| PharmaEngine, Inc. | 347.3 Million TWD | 126.652% |
| Savior Lifetec Corporation | 219.6 Million TWD | 142.15% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 153.744% |
| OBI Pharma, Inc. | -855.08 Million TWD | 89.175% |
| Acepodia, Inc. | -764.51 Million TWD | 87.893% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 79.882% |